tiprankstipranks
Advertisement
Advertisement

CABA Stock Latest News

Cabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed
RatingsCabaletta Bio Maintained at Buy as Emerging Rese-cel Data Support Preconditioning-Free Potential; $13 Price Target Reaffirmed
2d ago
CABA
Cabaletta Bio financing overhang concerns should be addressed, says Cantor
PremiumThe Fly
Cabaletta Bio financing overhang concerns should be addressed, says Cantor
3d ago
CABA
Cabaletta Bio Announces $150 Million Equity Offering
PremiumCompany Announcements
Cabaletta Bio Announces $150 Million Equity Offering
3d ago
8K
CABA
Cabaletta Bio reports promising RESET-PV and RESET-SLE data
PremiumCompany Announcements
Cabaletta Bio reports promising RESET-PV and RESET-SLE data
3d ago
8K
CABA
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data and Cellares Partnership Support Unchanged $16 Price Target
PremiumRatings
Cabaletta Bio: Buy Rating Reiterated as Rese-cel Data and Cellares Partnership Support Unchanged $16 Price Target
8d ago
CABA
Cabaletta Bio, Cellares report 10-year commercial supply agreement for rese-cel
PremiumThe FlyCabaletta Bio, Cellares report 10-year commercial supply agreement for rese-cel
9d ago
CABA
Cabaletta Bio, Cellares enter 10-year commercial agreement
Premium
The Fly
Cabaletta Bio, Cellares enter 10-year commercial agreement
9d ago
CABA
Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential
Premium
Ratings
Cabaletta Bio: RESET-MG Data and Differentiated Autoimmune Strategy Underpin Buy Rating and Upside Potential
16d ago
CABA
Cabaletta Bio Updates rese-cel Autoimmune Therapy Development Plans
PremiumCompany Announcements
Cabaletta Bio Updates rese-cel Autoimmune Therapy Development Plans
17d ago
8K
CABA
Patients dosed with Cabaletta’s rese-cel manufactured on Cellares’ Cell Shuttle
PremiumThe Fly
Patients dosed with Cabaletta’s rese-cel manufactured on Cellares’ Cell Shuttle
22d ago
CABA
Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock
PremiumMarket News
Morgan Stanley and Jefferies Analysts Forecast Over 350% Upside Potential for Cabaletta Bio Stock
1M ago
MS
JEF
Cabaletta Bio price target lowered to $13 from $14 at Morgan Stanley
PremiumThe Fly
Cabaletta Bio price target lowered to $13 from $14 at Morgan Stanley
1M ago
CABA
Cabaletta Bio price target raised to $16 from $15 at Guggenheim
PremiumThe FlyCabaletta Bio price target raised to $16 from $15 at Guggenheim
1M ago
CABA
Midday Fly By: Musk to start Terafab project, Elliott takes stake in Synopsys
Premium
The Fly
Midday Fly By: Musk to start Terafab project, Elliott takes stake in Synopsys
1M ago
MP
DBX
Cabaletta Bio Updates Rese-cel Programs and Financial Outlook
Premium
Company Announcements
Cabaletta Bio Updates Rese-cel Programs and Financial Outlook
1M ago
8K
CABA
Cabaletta Bio reports Q4 EPS (40c), consensus (47c)
PremiumThe Fly
Cabaletta Bio reports Q4 EPS (40c), consensus (47c)
1M ago
CABA
Cabaletta Bio, Inc. (CABA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Cabaletta Bio, Inc. (CABA) Q4 Earnings Cheat Sheet
2M ago
CABA
Cabaletta Bio participates in a conference call with William Blair
PremiumThe Fly
Cabaletta Bio participates in a conference call with William Blair
3M ago
CABA
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
3M ago
LI
IAG
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
PremiumWeekend UpdatesDave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
3M ago
AEO
ABEO
Cabaletta Bio: Advancing Rese-cel Across Autoimmune Indications with Streamlined Registrational Strategies and 2026 Value Catalysts Supporting Buy Rating
Premium
Ratings
Cabaletta Bio: Advancing Rese-cel Across Autoimmune Indications with Streamlined Registrational Strategies and 2026 Value Catalysts Supporting Buy Rating
4M ago
CABA
Cabaletta Bio Sets 2026 Strategy for Rese-cel Expansion
Premium
Company Announcements
Cabaletta Bio Sets 2026 Strategy for Rese-cel Expansion
4M ago
8K
CABA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >